1998
DOI: 10.1016/s0304-3940(97)00960-9
|View full text |Cite
|
Sign up to set email alerts
|

The immunosuppressant FK506 increases GAP-43 mRNA levels in axotomized sensory neurons

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0
2

Year Published

2000
2000
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 74 publications
(32 citation statements)
references
References 18 publications
0
30
0
2
Order By: Relevance
“…Presence of high levels of FKBP corresponds with the presence of high levels calcineurin [51,67]. The influence of FK506 on axon regeneration is predominantly through the binding to FKBP-12, which activates GAP-43 and the transforming growth factor (TGFb1) pathway [21,31]. The FK506--FKBP complex further binds to calcineurin, preventing the dephosphorylation of the nuclear factor of activated T cells and blocking the cascade of cytokine gene transcription.…”
Section: Action Mechanism Of Fk506mentioning
confidence: 99%
See 1 more Smart Citation
“…Presence of high levels of FKBP corresponds with the presence of high levels calcineurin [51,67]. The influence of FK506 on axon regeneration is predominantly through the binding to FKBP-12, which activates GAP-43 and the transforming growth factor (TGFb1) pathway [21,31]. The FK506--FKBP complex further binds to calcineurin, preventing the dephosphorylation of the nuclear factor of activated T cells and blocking the cascade of cytokine gene transcription.…”
Section: Action Mechanism Of Fk506mentioning
confidence: 99%
“…A broad range of dosages (0.3-10 mg/kg) of the FK506 for peripheral nerve regeneration has been reported in the literature [4,20,22,30,31,39,46,52,77]. It can be thought that the wide range of these dosages may be due to the administration route of the FK506.…”
Section: Administration Routes and Dosages Of Fk506mentioning
confidence: 99%
“…To date, it is still unclear whether inosine may also promote regeneration of injured neurites. Improved regeneration, together with up-regulation of GAP-43, has been also obtained by administration of the immunosuppressant drug tacrolimus (FK-506), both in peripheral (Gold et al, 1995(Gold et al, , 1998 and in central neurons (Masden et al, 1998).…”
Section: Pharmacological Stimulationmentioning
confidence: 99%
“…FK506 has been shown to exert neuroprotective effects in degenerative diseases, [30] ischemic insults, [31][32][33] spinal cord injury, [34,35] and neurite outgrowth in vitro. [36,37] Furthermore, treatment with FK506 has also been reported to enhance the rate of axonal regeneration in crush injury model [38][39][40][41] and in a peripheral nerve grafted into the injured spinal cord. [42] FK506 has been shown in many studies to enhance recovery after immediate [43] or delayed [29,38,44] nerve repair.…”
Section: Introductionmentioning
confidence: 99%